Uptrend on the daily chart: above its 50- and 200-day averages · 50-day above the 200-day · SuperTrend up since Jun 14 · above the Ichimoku cloud · RSI 59 · MACD below its signal · 2% below its 52-week high
None of the 29 investors followed here reported a position in RHC.AX in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a RHC.AX trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 27, 2026 | Siddle (Michael Stanley)Chairman of the Board | Sale at price 35.08 per share. | 1.00M | $35.08M |
| Mar 25, 2026 | Sargent (Steven Andrew)Director (Non-Executive) | Purchase at price 27.78 per share. | 619 | $17.20K |
| Mar 24, 2026 | Drummond (Craig)Director (Non-Executive) | Purchase at price 27.92 per share. | 15K | $418.76K |
| Mar 23, 2026 | Penrose (Karen Lee Collett)Director (Non-Executive) | Purchase at price 27.56 per share. | 701 | $19.32K |
| Nov 24, 2025 | Davis (Natalie)Managing Director | Other at price 0.00 per share. | 21.1K | $18 |
| Nov 30, 2024 | Mcnally (Craig Ralph)Former | — | 30K | — |
| Nov 14, 2024 | Mcnally (Craig Ralph)Chief Executive Officer | — | 14.6K | — |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 5.8 | 18.5 | -9.4 | -0.1 | -4.8 | 18.6 | 0.8 | 15.7 | 8.6 | -1.8 | +59.1% | ||
| 2025 | -2.3 | 2.0 | -0.8 | -2.5 | 15.2 | -4.2 | 5.7 | -12.6 | -6.4 | 1.2 | 14.7 | -6.7 | −0.5% |
| 2024 | -2.6 | 7.2 | 2.9 | -7.5 | -9.8 | 0.7 | -2.1 | -10.6 | 0.2 | -3.5 | -1.4 | -12.8 | −34.3% |
| 2023 | 3.0 | 1.4 | -1.5 | -2.8 | -11.3 | -1.9 | 4.7 | -12.7 | 0.8 | -6.1 | 1.0 | 7.0 | −18.7% |
| 2022 | -12.2 | 1.9 | 1.8 | 24.5 | -3.6 | -6.3 | -4.2 | 2.2 | -20.1 | 2.3 | 12.4 | -1.7 | −9.5% |
| 2021 | 1.3 | 4.8 | 1.5 | 0.5 | -5.7 | -0.9 | 1.9 | 7.4 | 1.0 | 1.1 | -5.1 | 7.0 | +15.0% |
| 2020 | 9.2 | -14.1 | -15.8 | 9.3 | 11.9 | -5.0 | -6.8 | 5.0 | 1.6 | -5.6 | 1.1 | -1.4 | −14.3% |
| 2019 | -1.7 | 14.2 | -0.7 | 1.5 | 6.9 | 3.5 | 0.7 | -9.8 | -1.2 | 5.6 | 6.6 | -0.6 | +25.6% |
| 2018 | -2.5 | -6.5 | -2.5 | 3.8 | -5.2 | -12.0 | 4.2 | -1.0 | -1.4 | 2.3 | -3.6 | 6.5 | −17.7% |
| 2017 | -2.2 | 4.5 | 0.2 | 2.6 | -3.9 | 6.8 | -4.1 | -3.2 | -8.8 | 7.4 | 4.3 | 0.5 | +2.7% |
| 2016 | -10.8 | 9.3 | -7.4 | 5.9 | 12.0 | -1.4 | 9.8 | 5.3 | -4.6 | -7.3 | -3.5 | -3.5 | +0.5% |
| 2015 | 4.1 | 12.5 | 0.5 | -6.9 | 1.5 | -3.2 | 8.8 | -6.6 | -6.4 | 6.1 | 8.1 | 1.3 | +19.0% |
| 2014 | 1.4 | 10.0 | -0.2 | -6.9 | 5.7 | -3.9 | 6.4 | 7.4 | -3.6 | 4.3 | 3.7 | 5.4 | +32.0% |
| 2013 | 8.3 | 8.7 | 0.6 | -1.0 | 8.1 | 3.6 | 2.8 | 1.4 | -3.1 | 7.2 | -0.2 | 11.7 | +58.6% |
| 2012 | -1.6 | -3.3 | 6.5 | 2.5 | 7.7 | 4.8 | 4.9 | 5.0 | -3.5 | -1.1 | 11.9 | 2.6 | +41.5% |
| 2011 | -4.2 | 4.0 | 7.6 | -5.2 | 1.9 | -1.4 | -3.9 | 1.8 | 6.7 | -1.1 | -1.2 | 3.8 | +8.3% |
| 2010 | 5.3 | 10.4 | 10.0 | -2.5 | 2.8 | 0.7 | 0.6 | 3.4 | 5.2 | 1.8 | -0.3 | 14.1 | +63.5% |
| 2009 | -2.9 | -0.2 | -2.3 | -6.1 | 18.9 | 4.9 | -9.0 | 0.0 | 4.5 | -3.6 | 2.6 | 0.3 | +4.7% |
| 2008 | 1.7 | 1.3 | -4.8 | 10.7 | -7.7 | -20.7 | 10.2 | 12.6 | -7.0 | 0.5 | -10.9 | 15.6 | −5.0% |
| 2007 | 3.1 | -0.9 | -0.9 | 0.6 | -2.2 | -1.0 | -4.5 | -1.7 | 1.7 | -0.7 | 3.3 | -0.2 | −3.5% |
Ramsay Health Care Limited owns and operates hospitals in Australia, the United Kingdom, France, and the Nordics. It offers services in various therapeutic areas, such as cardiology, oncology, orthopaedics, and mental health. The company also provides hospital in the home and telehealth services; and clinical specialties to private and self-insured patients, and patients referred by the NHS, as well as operates health clinics and pharmacy retail franchise network. It offers health care services to public and private patients. The company was founded in 1964 and is based in St Leonards, Australia.
Buy / hold / sell counts
No recent headlines.